| # | Title | Journal | Year | Citations |
|---|
| 1 | Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview | Lancet, The | 2000 | 1,959 |
| 2 | Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year | Journal of the American College of Cardiology | 1995 | 1,450 |
| 3 | Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction | Circulation | 1999 | 1,181 |
| 4 | Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) | European Heart Journal | 2006 | 1,144 |
| 5 | Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus | BMJ: British Medical Journal | 1997 | 1,130 |
| 6 | Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms | Journal of the American College of Cardiology | 2008 | 1,060 |
| 7 | Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity | European Heart Journal | 2005 | 979 |
| 8 | International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology | European Heart Journal | 2018 | 972 |
| 9 | Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study | Lancet, The | 2002 | 968 |
| 10 | Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study | Journal of the American College of Cardiology | 2002 | 855 |
| 11 | Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction | Circulation | 2000 | 688 |
| 12 | Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities | Nature Reviews Cardiology | 2019 | 684 |
| 13 | Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial | Lancet, The | 2016 | 620 |
| 14 | Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective | European Heart Journal | 2015 | 604 |
| 15 | The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) | Heart | 2010 | 537 |
| 16 | The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heart | European Heart Journal | 2004 | 532 |
| 17 | International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management | European Heart Journal | 2018 | 521 |
| 18 | Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients | Lancet, The | 1996 | 467 |
| 19 | Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’: Table 1 | British Journal of Sports Medicine | 2013 | 459 |
| 20 | Percutaneous Mitral Valve Edge-to-Edge Repair | Journal of the American College of Cardiology | 2014 | 398 |
| 21 | Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves | Arteriosclerosis, Thrombosis, and Vascular Biology | 1999 | 359 |
| 22 | Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction | Cardiovascular Research | 2007 | 329 |
| 23 | Alcohol Consumption and Risk of Atrial Fibrillation | Journal of the American College of Cardiology | 2014 | 316 |
| 24 | Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients | Diabetes Care | 1999 | 276 |
| 25 | Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves | Journal of the American College of Cardiology | 1994 | 272 |
| 26 | Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization | Journal of the American College of Cardiology | 2004 | 267 |
| 27 | The Swedish CArdioPulmonary BioImage Study: objectives and design | Journal of Internal Medicine | 2015 | 239 |
| 28 | Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure | American Journal of Cardiology | 1995 | 226 |
| 29 | Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine | Journal of the American College of Cardiology | 2001 | 223 |
| 30 | What are the costs of heart failure? | Europace | 2011 | 185 |
| 31 | β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction | Journal of the American College of Cardiology | 2017 | 174 |
| 32 | Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 | British Journal of Pharmacology | 2014 | 173 |
| 33 | Type 2 myocardial infarction in clinical practice | Heart | 2015 | 172 |
| 34 | Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes | European Heart Journal Supplements | 2001 | 168 |
| 35 | Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline | Journal of Clinical Pharmacology | 2006 | 168 |
| 36 | Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy | American Journal of Cardiology | 1999 | 165 |
| 37 | Matrix Metalloproteinases in Atherothrombosis | Progress in Cardiovascular Diseases | 2010 | 164 |
| 38 | Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis | Cardiovascular Research | 2021 | 164 |
| 39 | Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism | Regulatory Peptides | 2005 | 161 |
| 40 | Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure | Journal of Cardiac Failure | 1995 | 154 |
| 41 | Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients | Journal of the American Heart Association | 2018 | 153 |
| 42 | Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study | European Heart Journal | 2013 | 150 |
| 43 | Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid‐range, and reduced ejection fraction | European Journal of Heart Failure | 2017 | 148 |
| 44 | Normal electrocardiographic findings: recognising physiological adaptations in athletes | British Journal of Sports Medicine | 2013 | 146 |
| 45 | Patient selection for left ventricular assist devices | European Journal of Heart Failure | 2010 | 145 |
| 46 | Pharmacological possibilities for protection against myocardial reperfusion injury | Cardiovascular Research | 2002 | 144 |
| 47 | An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection | Journal of Heart and Lung Transplantation | 2017 | 142 |
| 48 | Urotensin II evokes potent vasoconstriction in humans in vivo | British Journal of Pharmacology | 2002 | 134 |
| 49 | Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry | European Journal of Heart Failure | 2014 | 134 |
| 50 | Incidence, Temporal Trends, and Prognostic Impact of Heart Failure Complicating Acute Myocardial Infarction | JACC: Heart Failure | 2015 | 130 |
